IVI’s Director of Research, Jason Shafrin, contributes to an op-ed for The Washington Post‘s “In Theory Blog: How we should pay for cures, according to economics.” In the commentary, Dr. Shafrin uses the example of a cure for Alzheimer’s disease to illustrate how various stakeholders demand very different pricing structures, and how IVI is working to create vigorous and transparent value assessment in healthcare, with the end goal of properly serving all parties.

Read the full article here.